Latest Prescription Drugs news
Acalabrutinib-Venetoclax Prolongs Survival in Previously Untreated Leukemia
posted February 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
posted February 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Olpasiran Leads to Significant Reduction in Oxidized Phospholipids
posted February 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Anifrolumab Tied to Less Organ Damage for Patients With Lupus
posted February 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors .jpg)
Recommendations Updated for Management of Anemia in CKD 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
Therapies Compared for Newly Diagnosed Multiple Sclerosis Related Articles
Initial Rx Length Tied to Long-Term Use of Z-Drugs 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Updated Recommendations Address Medications to Prevent Migraine in Adults 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders Monthly Specialist Briefings
Stay Connected
